CEO SUMMARY: It’s a surprise to most lab industry observers. AmeriPath, a company built around 400 anatomic pathologists working mostly in community hospitals, is acquiring a national reference/esoteric testing company. However, this deal may be better understood by looking at the motives of Welsh, Carson, Anderson & Stowe, the private equity firm which owns AmeriPath. […]
To access this post, you must purchase The Dark Report.